Literature DB >> 28385312

Myocardial Reparative Properties of Cardiac Mesenchymal Cells Isolated on the Basis of Adherence.

Marcin Wysoczynski1, Yiru Guo2, Joseph B Moore2, Senthilkumar Muthusamy2, Qianhong Li2, Marjan Nasr2, Hong Li2, Yibing Nong2, Wenjian Wu2, Alex A Tomlin2, Xiaoping Zhu2, Gregory Hunt2, Anna M Gumpert2, Michael J Book2, Abdur Khan2, Xian-Liang Tang2, Roberto Bolli3.   

Abstract

BACKGROUND: The authors previously reported that the c-kit-positive (c-kitPOS) cells isolated from slowly adhering (SA) but not from rapidly adhering (RA) fractions of cardiac mesenchymal cells (CMCs) are effective in preserving left ventricular (LV) function after myocardial infarction (MI).
OBJECTIVES: This study evaluated whether adherence to plastic alone, without c-kit sorting, was sufficient to isolate reparative CMCs.
METHODS: RA and SA CMCs were isolated from mouse hearts, expanded in vitro, characterized, and evaluated for therapeutic efficacy in mice subjected to MI.
RESULTS: Morphological and phenotypic analysis revealed that murine RA and SA CMCs are indistinguishable; nevertheless, transcriptome analysis showed that they possess fundamentally different gene expression profiles related to factors that regulate post-MI LV remodeling and repair. A similar population of SA CMCs was isolated from porcine endomyocardial biopsy samples. In mice given CMCs 2 days after MI, LV ejection fraction 28 days later was significantly increased in the SA CMC group (31.2 ± 1.0% vs. 24.7 ± 2.2% in vehicle-treated mice; p < 0.05) but not in the RA CMC group (24.1 ± 1.2%). Histological analysis showed reduced collagen deposition in the noninfarcted region in mice given SA CMCs (7.6 ± 1.5% vs. 14.5 ± 2.8% in vehicle-treated mice; p < 0.05) but not RA CMCs (11.7 ± 1.7%), which was associated with reduced infiltration of inflammatory cells (14.1 ± 1.6% vs. 21.3 ± 1.5% of total cells in vehicle and 19.3 ± 1.8% in RA CMCs; p < 0.05). Engraftment of SA CMCs was negligible, which implies a paracrine mechanism of action.
CONCLUSIONS: We identified a novel population of c-kit-negative reparative cardiac cells (SA CMCs) that can be isolated with a simple method based on adherence to plastic. SA CMCs exhibited robust reparative properties and offered numerous advantages, appearing to be more suitable than c-kitPOS cardiac progenitor cells for widespread clinical therapeutic application.
Copyright © 2017 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  fibrosis; inflammation; ischemic cardiomyopathy; myocardial infarction; repair

Mesh:

Substances:

Year:  2017        PMID: 28385312      PMCID: PMC5628504          DOI: 10.1016/j.jacc.2017.01.048

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  51 in total

Review 1.  TGF-β signaling in fibrosis.

Authors:  Anna Biernacka; Marcin Dobaczewski; Nikolaos G Frangogiannis
Journal:  Growth Factors       Date:  2011-07-11       Impact factor: 2.511

2.  Mesenchymal Stem Cells as a Biological Drug for Heart Disease: Where Are We With Cardiac Cell-Based Therapy?

Authors:  Cristina Sanina; Joshua M Hare
Journal:  Circ Res       Date:  2015-07-17       Impact factor: 17.367

Review 3.  Exosomes and cardiac repair after myocardial infarction.

Authors:  Susmita Sahoo; Douglas W Losordo
Journal:  Circ Res       Date:  2014-01-17       Impact factor: 17.367

4.  Proliferation and Recruitment Contribute to Myocardial Macrophage Expansion in Chronic Heart Failure.

Authors:  Hendrik B Sager; Maarten Hulsmans; Kory J Lavine; Marina B Moreira; Timo Heidt; Gabriel Courties; Yuan Sun; Yoshiko Iwamoto; Benoit Tricot; Omar F Khan; James E Dahlman; Anna Borodovsky; Kevin Fitzgerald; Daniel G Anderson; Ralph Weissleder; Peter Libby; Filip K Swirski; Matthias Nahrendorf
Journal:  Circ Res       Date:  2016-07-21       Impact factor: 17.367

5.  Sca-1+ cardiac progenitor cell therapy with cells overexpressing integrin-linked kinase improves cardiac function after myocardial infarction.

Authors:  Lin Ling; Jian Bai; Rong Gu; Chunying Jiang; Ran Li; Lina Kang; Albert Ferro; Biao Xu
Journal:  Transplantation       Date:  2013-05-27       Impact factor: 4.939

6.  Repeated Administrations of Cardiac Progenitor Cells Are Markedly More Effective Than a Single Administration: A New Paradigm in Cell Therapy.

Authors:  Yukichi Tokita; Xian-Liang Tang; Qianhong Li; Marcin Wysoczynski; Kyung U Hong; Shunichi Nakamura; Wen-Jian Wu; Wei Xie; Ding Li; Greg Hunt; Qinghui Ou; Heather Stowers; Roberto Bolli
Journal:  Circ Res       Date:  2016-06-30       Impact factor: 17.367

Review 7.  Pathological ventricular remodeling: mechanisms: part 1 of 2.

Authors:  Jana S Burchfield; Min Xie; Joseph A Hill
Journal:  Circulation       Date:  2013-07-23       Impact factor: 29.690

Review 8.  Paracrine mechanisms in adult stem cell signaling and therapy.

Authors:  Massimiliano Gnecchi; Zhiping Zhang; Aiguo Ni; Victor J Dzau
Journal:  Circ Res       Date:  2008-11-21       Impact factor: 17.367

9.  O-GlcNAcylation Negatively Regulates Cardiomyogenic Fate in Adult Mouse Cardiac Mesenchymal Stromal Cells.

Authors:  Ayesha Zafir; James A Bradley; Bethany W Long; Senthilkumar Muthusamy; Qianhong Li; Bradford G Hill; Marcin Wysoczynski; Sumanth D Prabhu; Aruni Bhatnagar; Roberto Bolli; Steven P Jones
Journal:  PLoS One       Date:  2015-11-13       Impact factor: 3.240

10.  Relative roles of CD90 and c-kit to the regenerative efficacy of cardiosphere-derived cells in humans and in a mouse model of myocardial infarction.

Authors:  Ke Cheng; Ahmed Ibrahim; M Taylor Hensley; Deliang Shen; Baiming Sun; Ryan Middleton; Weixin Liu; Rachel R Smith; Eduardo Marbán
Journal:  J Am Heart Assoc       Date:  2014-10-09       Impact factor: 5.501

View more
  26 in total

Review 1.  Mesenchymal Stem Cell-Based Therapy for Cardiovascular Disease: Progress and Challenges.

Authors:  Luiza Bagno; Konstantinos E Hatzistergos; Wayne Balkan; Joshua M Hare
Journal:  Mol Ther       Date:  2018-05-25       Impact factor: 11.454

2.  Pro-Angiogenic Actions of CMC-Derived Extracellular Vesicles Rely on Selective Packaging of Angiopoietin 1 and 2, but Not FGF-2 and VEGF.

Authors:  Marcin Wysoczynski; Asif Pathan; Joseph B Moore; Talha Farid; Jae Kim; Marjan Nasr; Yi Kang; Hong Li; Roberto Bolli
Journal:  Stem Cell Rev Rep       Date:  2019-08       Impact factor: 5.739

3.  Cardiac mesenchymal cells from failing and nonfailing hearts limit ventricular dilation when administered late after infarction.

Authors:  Timothy N Audam; Yibing Nong; Alex Tomlin; Andrea Jurkovic; Hong Li; Xiaoping Zhu; Bethany W Long; Yi Wei Zheng; Tyler Weirick; Kenneth R Brittian; Daniel W Riggs; Anna Gumpert; Shizuka Uchida; Yiru Guo; Marcin Wysoczynski; Steven P Jones
Journal:  Am J Physiol Heart Circ Physiol       Date:  2020-05-22       Impact factor: 4.733

Review 4.  New Paradigms in Cell Therapy: Repeated Dosing, Intravenous Delivery, Immunomodulatory Actions, and New Cell Types.

Authors:  Marcin Wysoczynski; Abdur Khan; Roberto Bolli
Journal:  Circ Res       Date:  2018-07-06       Impact factor: 17.367

5.  Cardiac mesenchymal cells from diabetic mice are ineffective for cell therapy-mediated myocardial repair.

Authors:  Parul Mehra; Yiru Guo; Yibing Nong; Pawel Lorkiewicz; Marjan Nasr; Qianhong Li; Senthilkumar Muthusamy; James A Bradley; Aruni Bhatnagar; Marcin Wysoczynski; Roberto Bolli; Bradford G Hill
Journal:  Basic Res Cardiol       Date:  2018-10-23       Impact factor: 17.165

6.  Epigenetically modified cardiac mesenchymal stromal cells limit myocardial fibrosis and promote functional recovery in a model of chronic ischemic cardiomyopathy.

Authors:  Joseph B Moore; Xian-Liang Tang; John Zhao; Annalara G Fischer; Wen-Jian Wu; Shizuka Uchida; Anna M Gumpert; Heather Stowers; Marcin Wysoczynski; Roberto Bolli
Journal:  Basic Res Cardiol       Date:  2018-11-16       Impact factor: 17.165

7.  A realistic appraisal of the use of embryonic stem cell-based therapies for cardiac repair.

Authors:  Marcin Wysoczynski; Roberto Bolli
Journal:  Eur Heart J       Date:  2020-07-01       Impact factor: 29.983

8.  Echocardiography-guided percutaneous left ventricular intracavitary injection as a cell delivery approach in infarcted mice.

Authors:  Yibing Nong; Yiru Guo; Alex Tomlin; Xiaoping Zhu; Marcin Wysoczynski; Qianhong Li; Roberto Bolli
Journal:  Mol Cell Biochem       Date:  2021-02-05       Impact factor: 3.396

9.  Single dose of synthetic microRNA-199a or microRNA-149 mimic does not improve cardiac function in a murine model of myocardial infarction.

Authors:  Yibing Nong; Yiru Guo; Anna Gumpert; Qianhong Li; Alex Tomlin; Xiaoping Zhu; Roberto Bolli
Journal:  Mol Cell Biochem       Date:  2021-07-21       Impact factor: 3.396

10.  Comparison of One and Three Intraventricular Injections of Cardiac Progenitor Cells in a Murine Model of Chronic Ischemic Cardiomyopathy.

Authors:  Yiru Guo; Yibing Nong; Qianhong Li; Alex Tomlin; Arunpreet Kahlon; Anna Gumpert; Jan Slezak; Xiaoping Zhu; Roberto Bolli
Journal:  Stem Cell Rev Rep       Date:  2020-10-28       Impact factor: 5.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.